Cargando…

Clinical practice in prostate PET imaging

Positron emission tomography (PET) imaging in prostate cancer has advanced significantly in the past decade with prostate cancer targeted radiopharmaceuticals now playing a growing role in diagnosis, staging, and treatment. This narrative review focuses on the most commonly used PET radiopharmaceuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huls, Sean J., Burkett, Brian, Ehman, Eric, Lowe, Val J., Subramaniam, Rathan M., Kendi, A. Tuba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666681/ https://www.ncbi.nlm.nih.gov/pubmed/38028142 http://dx.doi.org/10.1177/17588359231213618

Ejemplares similares

(177)Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
por: Sanli, Yasemin, et al.
Publicado: (2021)

Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management
por: Kuyumcu, Serkan, et al.
Publicado: (2021)

Stroke detection with 3 different PET tracers
por: Dundar, Ayca, et al.
Publicado: (2019)

Percutaneous Image-Guided Nodal Biopsy After 11C-Choline PET/CT for Biochemically Recurrent Prostate Cancer: Imaging Predictors of Disease and Clinical Implications
por: Welch, Brian T., et al.
Publicado: (2018)

PET and SPECT Imaging of ALS: An Educational Review
por: Jamali, Ayaan M., et al.
Publicado: (2023)

Another “great mimicker”: FDG-PET/CT imaging findings of sarcoid-like reaction
por: Kendi, A T K, et al.
Publicado: (2015)

Prostate Cancer—PET Imaging Update
por: Jetty, Sankarsh, et al.
Publicado: (2023)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

A case of granulomatous slack skin cutaneous T-cell lymphoma: PET/CT imaging findings
por: Kendi, A T, et al.
Publicado: (2015)

The Use of MRI and PET Imaging Studies for Prostate Cancer Management: Brief Update, Clinical Recommendations, and Technological Limitations
por: Mansbridge, Margaret, et al.
Publicado: (2019)

Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study
por: Shmidt, Eugenia, et al.
Publicado: (2016)

Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic β cells
por: Shim, Ji Yeon, et al.
Publicado: (2023)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
por: Lenzo, Nat P., et al.
Publicado: (2018)

New prospects for PET in prostate cancer imaging: a physicist's viewpoint
por: Conti, Maurizio
Publicado: (2014)

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
por: Li, Mei, et al.
Publicado: (2022)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review
por: Lisney, Anna Rebecca, et al.
Publicado: (2022)

Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer
por: Galgano, Samuel J., et al.
Publicado: (2018)

PET/CT imaging in prostate cancer
por: Barwick, Tara
Publicado: (2015)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

Isolated angioedema of the bowel caused by aspirin
por: Osman, Karim, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
por: Starr, Jason S, et al.
Publicado: (2020)

Amyloid- and tau-PET imaging in a familial prion kindred
por: Jones, David T., et al.
Publicado: (2018)

PET and PET/CT imaging of skeletal metastases
por: Cook, Gary J.R.
Publicado: (2010)

Clinical perspectives of PSMA PET/MRI for prostate cancer
por: Barbosa, Felipe de Galiza, et al.
Publicado: (2018)

Clinical implications of PET/CT in prostate cancer management
por: Rayn, Kareem N., et al.
Publicado: (2018)

Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer
por: Rasul, Sazan, et al.
Publicado: (2022)

Current role of PSMA-PET imaging in the clinical management of prostate cancer
por: Georgakopoulos, Alexander, et al.
Publicado: (2023)

Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
por: Zegers, Catharina M. L., et al.
Publicado: (2015)

Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer
por: Galgano, Samuel J., et al.
Publicado: (2022)

Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT
por: Rempel, Brian P., et al.
Publicado: (2017)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
por: Dondi, Francesco, et al.
Publicado: (2023)

Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer
por: Cereser, Lorenzo, et al.
Publicado: (2023)

Testicular Metastasis from Recurrent Gastroesophageal Junction Adenocarcinoma: Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Findings
por: Garg, Ishan, et al.
Publicado: (2018)

The Rise of Synaptic Density PET Imaging
por: Becker, Guillaume, et al.
Publicado: (2020)

The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability
por: Lee, Jeyeon, et al.
Publicado: (2022)

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
por: Halfdanarson, Thorvardur R., et al.
Publicado: (2023)

Recent advances of PET imaging in clinical radiation oncology
por: Unterrainer, M., et al.
Publicado: (2020)

PSMA PET imaging in the diagnosis and management of prostate cancer
por: Houshmand, Sina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j2v238kce547iladatma1c7o72